Financial Architects, Inc Amicus Therapeutics, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$8.02 - $13.25 $1,604 - $2,650	-200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $2,192 - $2,880	200 New	200 $2,000
Q4 2017 Feb 12, 2018	SELL	$12.51 - $16.24 $11,259 - $14,615	-900 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$11.74 - $15.78 $10,566 - $14,202	900	900 $14,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.79B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.